Skip to main content

Ventyx Biosciences, Inc.

VTYXDelisted Mar 4, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001851194

Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ventyx Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ventyx Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ventyx Biosciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Subramaniam SomuDirector0IndirectMar 4, 20262
Hulme AllisonDirector–Mar 4, 20261
Gujrathi SheilaDirector0IndirectMar 4, 20261
White William RichardDirector0Mar 4, 20261
Cadoret-Manier OnaizaDirector–Mar 4, 20261
Moore Matthew RichardChief Operating Officer–Mar 4, 20261
Nuss JohnCHIEF SCIENTIFIC OFFICER0Mar 4, 20262
Mohan RajuCEO AND PRESIDENT0Mar 4, 20262
Forman Mark SChief Medical Officer0Mar 4, 20262
Gonzales RoySenior VP, Finance0Mar 4, 20262
NSV Partners III GP LLC10% Owner7,102,969IndirectJun 26, 20240
NSV Partners III LP10% Owner7,102,969IndirectJun 26, 20240
Krueger Christopher WCHIEF BUSINESS OFFICER284,999Apr 3, 20240
Auster MartinCHIEF FINANCIAL OFFICER24,303Apr 3, 20240
Sandborn William J.See Remarks48,389Sep 1, 20230
Royston AaronDirector3,997,269IndirectApr 26, 20230
NSV Investments I, L.P.10% Owner13,274,786IndirectDec 15, 20220
Choksey JigarDirector–Jul 1, 20220
Goodman Corey S10% Owner3,997,269Jun 10, 20220
Adelman Robert J10% Owner3,997,269Jun 10, 20220
venBio Global Strategic Fund III, L.P.10% Owner, Other: See Remarks3,997,269Jun 10, 20220
Venbio Global Strategic GP III, Ltd10% Owner3,997,269Jun 10, 20220
Venbio Global Strategic GP III, L.P.10% Owner3,997,269Jun 10, 20220
Gaster RichardDirector–Jun 10, 20220
Drappa JornChief Medical Officer–Feb 4, 20220
Cormorant Asset Management, LPOther: Former 10% Owner1,410,303IndirectOct 27, 20210
Chen BihuaOther: Former 10% Owner1,410,303IndirectOct 27, 20210
Cormorant Global Healthcare Master Fund, LPOther: Former 10% Owner1,410,303IndirectOct 27, 20210
Cormorant Private Healthcare Fund III LP10% Owner1,410,303IndirectOct 27, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 25, 2021 (view filing)Oct 25Same dayRoyston AaronDirector, 10% OwnerPPurchase+312.5K$16.00+$5.00M+8.5%4.00M after
Oct 25, 2021 (view filing)7:40 PM ETOct 25Same dayGoodman Corey S and 4 others10% Owner, Other: See RemarksPPurchase+312.5K$16.00+$5.00M+8.5%4.00M afterDuplicate filing
Oct 27, 2021 (view filing)4:04 PM ETOct 252 daysCormorant Asset Management, LP and 3 othersOther: Former 10% OwnerPPurchase+625.0K$16.00+$10.0M+79.6%1.41M after
Nov 9, 2022 (view filing)Nov 72 daysSubramaniam SomuDirector, 10% OwnerSSale−3.94K$29.08−$114.4K0.0%16.9M after
Nov 9, 2022 (view filing)6:32 PM ETNov 72 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−3.94K$29.08−$114.4K0.0%16.9M after
Dec 2, 2022 (view filing)Nov 30-Dec 12 daysSubramaniam SomuDirector, 10% OwnerSSale−272.5K$29.01−$7.91M−1.6%16.6M after2 lots
Dec 2, 2022 (view filing)5:33 PM ETNov 30-Dec 12 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−272.5K$29.01−$7.91M−1.6%16.6M after2 lots
Dec 6, 2022 (view filing)Dec 51 dayNuss JohnChief Scientific OfficerSSale−50.0K$28.22−$1.41M−16.2%258.7K after2 lots
Dec 6, 2022 (view filing)Dec 24 daysKrueger Christopher WChief Business OfficerSSale−50.0K$29.01−$1.45M−14.2%302.7K after
Dec 6, 2022 (view filing)Dec 24 daysAuster MartinChief Financial OfficerSSale−97.6K$29.01−$2.83M−67.2%47.6K after
Dec 6, 2022 (view filing)Dec 2-54 daysMohan RajuChief Executive OfficerSSale−300.0K$28.97−$8.69M−16.3%1.54M after3 lots
Dec 15, 2022 (view filing)Dec 132 daysNuss JohnChief Scientific OfficerSSale−35.0K$34.32−$1.20M−13.5%223.7K after
Dec 15, 2022 (view filing)Dec 132 daysKrueger Christopher WChief Business OfficerSSale−30.0K$34.46−$1.03M−9.9%272.7K after
Dec 16, 2022 (view filing)5:00 PM ETDec 142 daysSandborn William J.See RemarksSSale−21.8K$33.87−$737.1K−31.0%48.4K after
Dec 16, 2022 (view filing)5:00 PM ETDec 142 daysSandborn William J.See RemarksSSale−20.9K$33.87−$708.6K−37.5%34.9K after
Dec 19, 2022 (view filing)Dec 15-164 daysSubramaniam SomuDirector, 10% OwnerSSale−300.0K$33.28−$9.98M−2.3%13.0M after2 lots
Dec 19, 2022 (view filing)6:56 PM ETDec 15-164 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−300.0K$33.28−$9.99M−2.3%13.0M after2 lots
Dec 23, 2022 (view filing)Dec 221 dayKrueger Christopher WChief Business OfficerSSale−3.65K$31.61−$115.5K−1.3%282.7K after
Dec 23, 2022 (view filing)Dec 221 dayNuss JohnChief Scientific OfficerSSale−13.8K$31.61−$436.6K−5.3%244.8K after
Dec 23, 2022 (view filing)Dec 221 dayMohan RajuChief Executive OfficerSSale−55.4K$31.61−$1.75M−3.3%1.60M after
Jan 24, 2023 (view filing)Jan 231 dayWhite William RichardDirectorSSale−33.4K$35.10−$1.17M−100.0%0 after3 lots
Mar 31, 2023 (view filing)Mar 301 dayGujrathi SheilaDirectorSSale−100.0K$33.73−$3.37M−100.0%0 after
Apr 5, 2023 (view filing)Apr 41 dayAuster MartinChief Financial OfficerSSale−21.0K$30.76−$646.0K−30.6%47.6K after3 lots
Apr 5, 2023 (view filing)7:13 PM ETApr 32 daysNuss JohnChief Scientific OfficerSSale−30.0K$32.87−$986.2K−10.9%244.8K after2 lots
Apr 7, 2023 (view filing)Apr 5-62 daysMohan RajuChief Executive OfficerSSale−20.7K$29.52−$612.4K−1.3%1.58M after3 lots
Apr 12, 2023 (view filing)Apr 102 daysMohan RajuChief Executive OfficerSSale−9.26K$29.01−$268.5K−0.6%1.57M after
Apr 14, 2023 (view filing)Apr 12-132 daysSubramaniam SomuDirector, 10% OwnerSSale−100.0K$30.22−$3.02M−1.0%9.98M after2 lots
Apr 14, 2023 (view filing)6:33 PM ETApr 12-132 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−100.0K$30.23−$3.02M−1.0%9.98M after2 lots
Apr 19, 2023 (view filing)Apr 172 daysAuster MartinChief Financial OfficerSSale−7.00K$33.00−$231.0K−12.8%47.6K after
Apr 25, 2023 (view filing)Apr 21-254 daysSubramaniam SomuDirector, 10% OwnerSSale−100.0K$38.54−$3.85M−1.0%9.88M after4 lots
Apr 25, 2023 (view filing)9:39 PM ETApr 21-254 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−100.0K$38.54−$3.85M−1.0%9.88M after4 lots
Apr 27, 2023 (view filing)Apr 252 daysAuster MartinChief Financial OfficerSSale−28.0K$38.03−$1.06M−37.0%47.6K after3 lots
May 1, 2023 (view filing)5:36 PM ETApr 283 daysSandborn William J.See RemarksSSale−10.8K$36.96−$398.8K−18.2%48.4K after2 lots
May 4, 2023 (view filing)Apr 331 daysKrueger Christopher WChief Business OfficerSSale−15.0K$32.88−$493.2K−5.2%276.1K afterAmended
May 4, 2023 (view filing)May 31 dayKrueger Christopher WChief Business OfficerSSale−15.0K$38.65−$579.7K−5.2%276.1K after2 lots
May 4, 2023 (view filing)4:10 PM ETMay 31 dayNuss JohnChief Scientific OfficerSSale−10.0K$38.64−$386.4K−3.9%244.8K after2 lots
May 5, 2023 (view filing)May 5Same dayMohan RajuChief Executive OfficerSSale−30.0K$39.28−$1.18M−1.9%1.54M after
May 16, 2023 (view filing)7:10 PM ETMay 151 daySandborn William J.See RemarksSSale−3.49K$36.47−$127.2K−9.1%34.7K after3 lots
Jun 1, 2023 (view filing)5:53 PM ETMay 311 daySandborn William J.See RemarksSSale−10.6K$34.26−$364.2K−18.0%48.4K after
Jun 6, 2023 (view filing)Jun 51 dayMohan RajuChief Executive OfficerSSale−30.0K$34.36−$1.03M−1.9%1.51M after2 lots
Jun 6, 2023 (view filing)7:19 PM ETJun 51 dayKrueger Christopher WChief Business OfficerSSale−15.0K$34.36−$515.4K−5.1%276.5K after2 lots
Jun 7, 2023 (view filing)Jun 61 dayAuster MartinChief Financial OfficerSSale−28.0K$34.64−$969.9K−37.0%47.6K after2 lots
Jun 7, 2023 (view filing)6:59 PM ETJun 52 daysNuss JohnChief Scientific OfficerSSale−10.0K$34.35−$343.5K−3.9%244.8K after2 lots
Jun 8, 2023 (view filing)Jun 6-72 daysSubramaniam SomuDirector, 10% OwnerSSale−40.0K$35.59−$1.42M−0.4%9.84M after3 lots
Jun 8, 2023 (view filing)9:47 PM ETJun 6-72 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−40.0K$35.59−$1.42M−0.4%9.84M after3 lots
Jun 16, 2023 (view filing)Jun 142 daysSubramaniam SomuDirector, 10% OwnerSSale−50.0K$35.08−$1.75M−0.5%9.79M after
Jun 16, 2023 (view filing)Jun 151 daySandborn William J.See RemarksSSale−3.49K$34.16−$119.1K−10.1%31.2K after2 lots
Jun 16, 2023 (view filing)7:15 PM ETJun 142 daysNSV Partners III GP LLC and 1 other10% OwnerSSale−50.0K$35.08−$1.75M−0.5%9.79M after
Jun 27, 2023 (view filing)6:01 PM ETJun 234 daysSandborn William J.See RemarksSSale−10.8K$32.70−$352.8K−18.2%48.4K after2 lots
Jul 5, 2023 (view filing)Jul 32 daysSandborn William J.See RemarksSSale−11.9K$40.00−$476.0K−19.7%48.4K after